BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25178153)

  • 1. Comparison of two platelet transfusion strategies to minimize ABO-nonidentical transfusion, outdating, and shortages using a computer-simulated "virtual blood bank".
    Jackups R; Kymes S
    Transfusion; 2015 Feb; 55(2):348-56. PubMed ID: 25178153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
    Henrichs KF; Howk N; Masel DS; Thayer M; Refaai MA; Kirkley SA; Heal JM; Blumberg N
    Transfusion; 2012 Mar; 52(3):635-40. PubMed ID: 21895675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
    Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies.
    Riley W; Smalley B; Pulkrabek S; Clay ME; McCullough J
    Transfusion; 2012 Sep; 52(9):1957-67. PubMed ID: 22320153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
    Yazer MH; Raval JS; Triulzi DJ; Blumberg N
    Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
    Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
    Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency use of prethawed Group A plasma in trauma patients.
    Zielinski MD; Johnson PM; Jenkins D; Goussous N; Stubbs JR
    J Trauma Acute Care Surg; 2013 Jan; 74(1):69-74; discussion 74-5. PubMed ID: 23271079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.
    Fung MK; Downes KA; Shulman IA
    Arch Pathol Lab Med; 2007 Jun; 131(6):909-16. PubMed ID: 17550318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Root cause analysis of non-infectious transfusion complications and the lessons learnt.
    Karim F; Moiz B; Shamsuddin N; Naz S; Khurshid M
    Transfus Apher Sci; 2014 Feb; 50(1):111-7. PubMed ID: 24239270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO and platelet transfusion revisited.
    Heal JM; Rowe JM; Blumberg N
    Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive program to minimize platelet outdating.
    Fuller AK; Uglik KM; Braine HG; King KE
    Transfusion; 2011 Jul; 51(7):1469-76. PubMed ID: 21303370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey.
    Lozano M; Heddle N; Williamson LM; Wang G; AuBuchon JP; Dumont LJ;
    Transfusion; 2010 Aug; 50(8):1743-8. PubMed ID: 20456712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood.
    Pai M; Cook R; Barty R; Eikelboom J; Lee KA; Heddle N
    Transfusion; 2016 Mar; 56(3):550-7. PubMed ID: 26472598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
    Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients.
    Lin Y; Callum JL; Coovadia AS; Murphy PM
    Transfusion; 2002 Feb; 42(2):166-72. PubMed ID: 11896330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.